Unilabs Officially Welcomes Atalmedial

Utrecht and Amsterdam, 7 November 2023:  Unilabs, a leading international provider of diagnostic services, is thrilled to announce the official completion of its acquisition of Atalmedial, a leading provider of laboratory diagnostics and thrombosis care, marking a significant enhancement to its network of specialised diagnostic laboratories in the Netherlands. With the addition of Atalmedial, Unilabs has formed a robust organisation operating across a substantial part of the Netherlands, specialising in laboratory diagnostics and thrombosis care.

Jeroen van Roon, General Manager of Unilabs Netherlands, stated, "We recently joined forces with regional partners Saltro, Medlon, SHO, and now Atalmedial. Our mission is to provide advanced integrated diagnostics that are easily accessible throughout the Netherlands. Together, we offer trusted insights, empowering our clients to make informed healthcare choices about their health and that of their patients."

Unilabs is actively building an extensive network of specialised laboratories with expertise in every diagnostic field, ranging from laboratory tests to imaging and DNA analysis. This allows the organisation to foster local innovation, implement intelligent technology, tap into international expertise, and share knowledge and insights.

Claudia Pronk, former Chair of Atalmedial and current Head of Medical Unilabs Netherlands, expressed, "The Dutch healthcare system demands sustainable diagnostic solutions, and we are committed to providing long-term support. Our strength lies in an exceptional team, strong partnerships with local healthcare providers, and extensive expertise. Together, we lay the groundwork for a healthier future for everyone. The well-being of individuals is at the core of everything we do."